Sizzling Stock Picks

[AAAAMHIM]

$NSPX 0055 thin to .12. Shares locked. ITS-BREAKTHROUGH-DRUG-ON-THE-NEWS!
https://t.co/4xpVadG901 #biotech
UNKNOWN #BIOTECH GEM.

Brain cancer Drug.

Once traded $250+ on Nasdaq, silent news after being dark for 9 months

$1.8 billion hedgefund that strictly focuses on biotech Loaded 10% of the shares SILENTLY released in 13G filing last month. NSPX is the only pennystock that is in their portfolio.

One of THE THINEST FLOATS out of the over 10,000 in the OTC market.

$NSPX 0055?!! Only 150 million A/S? Over or near 140 million O/S??! SHARES MAXED OUT. #BIOTECH cancer stock with BRAIN CANCER DRUG?! A mathematical JEWEL, in my honest opinion. Relation of shares held vs S/S & price highly favors the trader her imo. Learn the dance ???????????Trust me we are adding & LOCKING THIS FLOAT UP. And with the help of Sabby Capital A HEDGEFUND THAT SPECIALIZES IN #BIOTECH BIG BOARD STOCKS, IS WORTH $1.8 BILLION just loaded 10% of the shares out there! WHY INVEST IN A PENNYSTOCK BIOTECH NOW? HOW many shares do you think R out there right now? Only old school LOW FLOAT PROs understand where I'm heading with this. Only they have their calculators out & understand the RELEVANCE of share structure IN RELATION to price. 150 million A/S at 0055? WITH A CANCER PATENT & product???!!

Let's just say the O/S is still at last reported 122 million which it certainly isnt. 150 million A/S minus 122 equals only 28 million shares total out there & I didnt even add the shares owned by Sabby Capital. $NSPX IS LOCKED FELLAS dont let them rattle u. About 2 go PARABOLIC

MUST WATCH videos about Mipsagargin: 

Intro into Mipsagargin by Inspyr(formerly Genspera): 

https://t.co/ACgcDSUDAI ;

NSPX in the News- Mipsagargin Breakthrough Drug- Potential replacement for chemotherapy: 

https://t.co/GWGgYnWU6GPhysicians React to Phase 2 Update on GenSpera’s Mipsagargin in Hepatocellular Carcinoma at ASCO GI: 

https://t.co/0Eii7oPRj1 ;

Mipsagargin latest update as of June 2018 (with other patent info): 
https://t.co/CeKyBx9BF9 ;

https://t.co/V8eIGh6IyCQ/A with the Doctor behind Mipsagargin: 
https://t.co/midEoHRLgX ;

3. Meet our CEO- Chris Lowe: 

https://t.co/lmHuWJj1kO ;

Chris Lowe joined FLG in 2014, serves on the Firm’s Management Committee and was elected Co-Managing Partner in 2018. Chris has over 15 years of seniorInspyr to License Oncology Related Compounds to Ridgeway Therapeutics Inc. 
9/17/18, 8:00 AM 
WESTLAKE VILLAGE, Calif., Sept. 17, 2018  
https://t.co/lVY4S5yUbN ;

***This licensing deal does not cover Mipsagargin so there may be another separate deal in the works....Mipsagargin-First-in-Class Agent is Well Tolerated in Liver Cancer Patients*** 
https://t.co/8tBXIhsl8N ;
6. Recent Inside significant stake by Hedge Fund Sabby Management: 
NEW 13G Filing: 
https://t.co/Dm3M1zbFiJ ;
  Sabby Management, LLC is an employee owned investment manager.$NSPX did you know same guy who runs Ridgeway Therapeutics (partnering with NSPX to advance and fund our clinical studies) was VP of clinical development of CV Therapeutics (bought out by Gilead for $1.8 billion in 2009)??? https://t.co/cSRtp7xi5l

If u own shares of $NSPX let me know so I can add you to the NSPX chat. I took $VDRM from 0014 to 7 cents while fighting through the naysayers. $RXMD 0016 TO 27 CENTS with naysayers trying their hardest to use their broken DD. $FLCR 0017 to 21 cents, SHMP .02 (NO ONE HEARD OF IT OR WANTED SHMP now it's the hottest thing in the OTC broke 60 cents) DEGH 0025 to $1.36 etc?????For those unfamiliar with what a FLOAT LOCKDOWN IS READ. ITS ALL MATH NOW. Nothing any short or market maker can do to stop our EMINENT PARABOLIC accent. Gonna eat these up & add new shareholders day by day. Pebbles in an hourglass fall 1 at a time. MATH??
https://t.co/vfkK5ntseX

NSPX will not be at 0055 for long.

Only 150 million authorized shares??

NEW UPDATE TO DRUG MISPARGARIN LAST NOVEMBER, not pr'ed not in filings can only be found on mipsagarin site. They added a whole new ATOMIC structure!! HUGE. Shhhhhhhhh

NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX NSPX